Peptide News Digest

#Nutrition

2 stories

Research · View digest

Delivered Meals or a Wellness App Cut Weight Regain by About 7 Points in the Four Months After Stopping GLP-1 Drugs, Pilot Trial Finds

Researchers at Tufts University and UT Southwestern reported in Obesity Science & Practice on October 7, 2026 a pilot randomized trial of 39 adults who had lost weight on GLP-1 drugs and were stopping them, assigned to usual care (14), a digital wellness app (12), or medically tailored meals (13). Over the first four months off the drug, both the app and meal groups gained less weight than the control group, by 7.16 and 7.17 percentage points of body weight. Weight was an exploratory outcome, measured with Bluetooth scales at home, and the authors said larger and longer trials are needed.

Research · View digest

Medical Xpress / San Raffaele Study: AI Dietary Tracking Reveals GLP-1 Users Get Only 0.6 g/kg/day Protein — 88% Below Recommendations

A study published in Medical Xpress analyzed 5,741 days of AI-powered dietary-tracking data from 332 adults with overweight or obesity. GLP-1 users consumed significantly less energy (1,102 vs 1,281 kcal/day) and protein (53.8 vs 62.0 g/day) than non-users. Weight-adjusted daily protein intake was 0.6 g/kg/day among GLP-1 users, with 88% falling below the Italian national 0.9 g/kg/day recommendation. IRCCS San Raffaele researchers warn of nutritional deficiencies and muscle-health risks during GLP-1 therapy.